Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|July 26, 2022
HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and managementSonia Wolf, Marie Vercruyssen, Lucy Cook
Clinical Lymphoma, Myeloma & Leukemia|April 14, 2020
RETRACTED: Drug-Induced ThrombocytopeniaMaroun Sadek, Georges El Hachem, Marie Vercruyssen
Cancers|February 25, 2022
Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective AnalysisFulvio Massaro, Nathalie Meuleman, Dominique Bron, et al.
European Journal of Haematology|May 3, 2018
Long-term follow-up of 2 patients treated with <sup>90</sup> Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphomaSophie C Golstein, Kristoff Muylle, Marie Vercruyssen, et al.
Biomedicines|May 25, 2024
Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative DisordersFulvio Massaro, Fabio Andreozzi, Tom Abrassart, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 27, 2025
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myelomaWendy Delbart, Ioannis Karfis, Marie Vercruyssen, et al.
EJNMMI Reports|July 27, 2025
First-in-human experience of radiopharmaceutical therapy with [<sup>177</sup>Lu]Lu-DOTATATE in patients with advanced multiple myelomaWendy Delbart, Marie Vercruyssen, Rachele Danieli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 20, 2015
Myocardial inflammation in experimental acute right ventricular failure: Effects of prostacyclin therapyCéline Dewachter, Asmae Belhaj, Benoit Rondelet, et al.
Cancers|May 16, 2023
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATEWendy Delbart, Gwennaëlle Marin, Basile Stamatopoulos, et al.
Pageof 1